562 related articles for article (PubMed ID: 20620694)
1. Intrahepatic transit time predicts liver fibrosis in patients with chronic hepatitis B: quantitative assessment with contrast-enhanced ultrasonography.
Li N; Ding H; Fan P; Lin X; Xu C; Wang W; Xu Z; Wang J
Ultrasound Med Biol; 2010 Jul; 36(7):1066-75. PubMed ID: 20620694
[TBL] [Abstract][Full Text] [Related]
2. Hepatic vein transit time of SonoVue: a comparative study with Levovist.
Lim AK; Patel N; Eckersley RJ; Goldin RD; Thomas HC; Cosgrove DO; Taylor-Robinson SD; Blomley MJ
Radiology; 2006 Jul; 240(1):130-5. PubMed ID: 16720867
[TBL] [Abstract][Full Text] [Related]
3. Tissue Doppler imaging and tissue strain imaging for the evaluation of hepatic fibrosis in patients with chronic hepatitis B.
Wang Y; Wu Z; Ju Y; Cao L; Shi L; Tong F; Jiang X; Zhu C
Ultrasound Med Biol; 2013 Sep; 39(9):1527-35. PubMed ID: 23791352
[TBL] [Abstract][Full Text] [Related]
4. Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C.
Lim AK; Taylor-Robinson SD; Patel N; Eckersley RJ; Goldin RD; Hamilton G; Foster GR; Thomas HC; Cosgrove DO; Blomley MJ
Gut; 2005 Jan; 54(1):128-33. PubMed ID: 15591518
[TBL] [Abstract][Full Text] [Related]
5. Quantitative diagnosis of early-stage liver cirrhosis with contrast-enhanced ultrasound--a clinical study.
Shi Y; Wang XH; Xia GC; Lei CG
Adv Clin Exp Med; 2012; 21(3):385-90. PubMed ID: 23214202
[TBL] [Abstract][Full Text] [Related]
6. [Clinical value of contrast-enhanced ultrasound in evaluating portal hypertension in patients with decompensated liver cirrhosis].
Zhuang Y; Ding H; Han H; Mao F; Luo JJ; Chen SY; Wang WP
Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):270-4. PubMed ID: 27470625
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced ultrasound to evaluate the severity of chronic hepatitis C.
Ridolfi F; Abbattista T; Marini F; Vedovelli A; Quagliarini P; Busilacchi P; Brunelli E
Dig Liver Dis; 2007 Oct; 39(10):929-35. PubMed ID: 17669702
[TBL] [Abstract][Full Text] [Related]
8. Liver contrast enhanced ultrasound perfusion imaging in the evaluation of chronic hepatitis C fibrosis: preliminary results.
Orlacchio A; Bolacchi F; Petrella MC; Pastorelli D; Bazzocchi G; Angelico M; Simonetti G
Ultrasound Med Biol; 2011 Jan; 37(1):1-6. PubMed ID: 21144954
[TBL] [Abstract][Full Text] [Related]
9. Does hepatic vein transit time performed with contrast-enhanced ultrasound predict the severity of hepatic fibrosis?
Tang A; Kim TK; Heathcote J; Guindi M; Jang HJ; Karshafian R; Burns PN; Wilson SR
Ultrasound Med Biol; 2011 Dec; 37(12):1963-9. PubMed ID: 22033130
[TBL] [Abstract][Full Text] [Related]
10. Application of the Hepatic Transit Time (HTT) in Evaluation of Portal Vein Pressure in Gastroesophageal Varices Patients.
Lin YQ; Jiang B; Li HQ; Jin CX; Wang H
J Ultrasound Med; 2019 Sep; 38(9):2305-2314. PubMed ID: 30609088
[TBL] [Abstract][Full Text] [Related]
11. Characterization of focal liver lesions by means of assessment of hepatic transit time with contrast-enhanced US.
Zhou X; Liu JB; Luo Y; Yan F; Peng Y; Lin L; Zhuang H
Radiology; 2010 Aug; 256(2):648-55. PubMed ID: 20656845
[TBL] [Abstract][Full Text] [Related]
12. Hepatic perfusion parameters of contrast-enhanced ultrasonography correlate with the severity of chronic liver disease.
Liu D; Qian L; Wang J; Hu X; Qiu L
Ultrasound Med Biol; 2014 Nov; 40(11):2556-63. PubMed ID: 25218453
[TBL] [Abstract][Full Text] [Related]
13. Hepatic vein transit time of second-generation ultrasound contrast agent: new tool in the assessment of portal hypertension.
Luisa S; Vitale G; Sorbo AR; Maurizio P; Lodovico RG
J Ultrasound; 2017 Mar; 20(1):43-52. PubMed ID: 28298943
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced ultrasonography could be a non-invasive method for differentiating none or mild from severe fibrosis in patients with biopsy proven non-alcoholic fatty liver disease.
Nasr P; Hilliges A; Thorelius L; Kechagias S; Ekstedt M
Scand J Gastroenterol; 2016 Sep; 51(9):1126-32. PubMed ID: 27161854
[TBL] [Abstract][Full Text] [Related]
15. Application of Hepatic Transit Time and Shear Wave Velocity in Assessing Portal Pressure in Patients with Cirrhotic Portal Hypertension.
Lin Y; Liu Y; Jiang B; Li W; Li H; Wang H
Ultrasound Med Biol; 2021 Feb; 47(2):272-278. PubMed ID: 33153804
[TBL] [Abstract][Full Text] [Related]
16. Assessment of hepatic fibrosis by analysis of the dynamic behaviour of microbubbles during contrast ultrasonography.
Ishibashi H; Maruyama H; Takahashi M; Fujiwara K; Imazeki F; Yokosuka O
Liver Int; 2010 Oct; 30(9):1355-63. PubMed ID: 20704652
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent.
Albrecht T; Blomley MJ; Cosgrove DO; Taylor-Robinson SD; Jayaram V; Eckersley R; Urbank A; Butler-Barnes J; Patel N
Lancet; 1999 May; 353(9164):1579-83. PubMed ID: 10334257
[TBL] [Abstract][Full Text] [Related]
18. Hepatic transit time analysis using contrast-enhanced ultrasound with BR1: A prospective study comparing patients with liver metastases from colorectal cancer with healthy volunteers.
Hohmann J; Müller C; Oldenburg A; Skrok J; Frericks BB; Wolf KJ; Albrecht T
Ultrasound Med Biol; 2009 Sep; 35(9):1427-35. PubMed ID: 19540656
[TBL] [Abstract][Full Text] [Related]
19. Color Doppler velocity profile and contrast-enhanced ultrasonography in assessment of liver cirrhosis.
Lin LW; Duan XJ; Wang XY; Xue ES; He YM; Gao SD; Yu LY
Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):34-9. PubMed ID: 18234636
[TBL] [Abstract][Full Text] [Related]
20. Hepatic Vein Arrival Time for Diagnosis of Liver Cirrhosis: A 10-Year Single-Center Experience With Contrast-Enhanced Sonography.
Abbattista T; Ridolfi F; Consalvo GT; Brunelli E
J Ultrasound Med; 2016 Oct; 35(10):2121-8. PubMed ID: 27503751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
